Federal Grant Award Summary

Halogen Power, Inc. received a $305,000 Small Business Innovation Research (SBIR) Phase I project grant from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) effective July 1, 2026 through June 30, 2027. The company will develop a pre-commercial prototype of a high-energy primary (non-rechargeable) battery for wearable medical and Internet of Things devices. The innovation employs a novel fluoride-conversion-based battery chemistry with a hybrid catholyte (cathode-electrolyte combination) designed to increase energy density by over 50 percent compared to state-of-the-art commercial batteries, enabling either 50 percent longer battery life or 30 percent smaller battery sizes.

The research advances fundamental battery chemistry understanding while demonstrating a new architecture that stores energy in both solid and liquid phases. By minimizing inactive weight in the battery cell through integration with commercial solid cathodes such as carbon monofluoride, the technology addresses a critical constraint in wearable device design and remote monitoring applications where extended battery life directly determines device functionality and patient quality of life. The company plans to pursue commercialization through a business-to-business model targeting wearables as the initial market segment.